GQG Partners’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-46,487
| Closed | -$7.41M | – | 69 |
|
2023
Q1 | $7.41M | Buy |
46,487
+2,507
| +6% | +$400K | 0.02% | 55 |
|
2022
Q4 | $7.11M | Sell |
43,980
-429
| -1% | -$69.3K | 0.02% | 60 |
|
2022
Q3 | $5.96M | Sell |
44,409
-3,007,211
| -99% | -$404M | 0.02% | 57 |
|
2022
Q2 | $468M | Buy |
3,051,620
+2,882,655
| +1,706% | +$442M | 1.15% | 29 |
|
2022
Q1 | $27.4M | Buy |
168,965
+131,780
| +354% | +$21.4M | 0.06% | 47 |
|
2021
Q4 | $5.03M | Buy |
37,185
+25,358
| +214% | +$3.43M | 0.01% | 57 |
|
2021
Q3 | $1.28M | Buy |
11,827
+3,354
| +40% | +$362K | ﹤0.01% | 57 |
|
2021
Q2 | $954K | Sell |
8,473
-3,105,796
| -100% | -$350M | ﹤0.01% | 59 |
|
2021
Q1 | $337M | Sell |
3,114,269
-104,339
| -3% | -$11.3M | 1.23% | 32 |
|
2020
Q4 | $345M | Buy |
+3,218,608
| New | +$345M | 1.18% | 30 |
|